213 related articles for article (PubMed ID: 8210644)
1. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
[No Abstract] [Full Text] [Related]
2. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death.
van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER
Leukemia; 2005 Oct; 19(10):1845-7. PubMed ID: 16107891
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children].
Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1989; (2):30-4. PubMed ID: 2726363
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
[TBL] [Abstract][Full Text] [Related]
6. Reply to Gaipa et Al.
van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER
Leukemia; 2005 Oct; 19(10):1858. PubMed ID: 16107890
[No Abstract] [Full Text] [Related]
7. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.
Tiensiwakul P; Lertlum T; Nuchprayoon I; Seksarn P
Asian Pac J Allergy Immunol; 1999 Mar; 17(1):17-21. PubMed ID: 10403005
[TBL] [Abstract][Full Text] [Related]
9. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
10. Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria.
Taskov H; Dimitrova E; Serbinova M; Mendisova L; Bobev D
Leuk Res; 1995 Nov; 19(11):877-81. PubMed ID: 8551806
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotyping of acute leukemia by flow cytometry: closing the black holes of morphology.
Santos EC; Castro-e-Melo JV
Bull Cancer; 1995 Jan; 82(2):117-21. PubMed ID: 10846528
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
[TBL] [Abstract][Full Text] [Related]
13. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Lenormand B; Béné MC; Lesesve JF; Bastard C; Tilly H; Lefranc MP; Faure GC; Garand R; Falkenrodt A; Kandel G; Solary E; Maynadié M; Callat MP; Thouret F; Monconduit M; Vannier JP
Leuk Lymphoma; 1998 Jan; 28(3-4):329-42. PubMed ID: 9517504
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic aberrancy in adult acute lymphoblastic leukemia.
Ross CW; Stoolman LM; Schnitzer B; Schlegelmilch JA; Hanson CA
Am J Clin Pathol; 1990 Nov; 94(5):590-9. PubMed ID: 2239822
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups.
Giordano P; Del Vecchio GC; Santoro N; Arcamone G; Coppola B; Altomare M; Schettini F; Iolascon A; De Mattia D
Pediatr Hematol Oncol; 2000 Dec; 17(8):667-72. PubMed ID: 11127398
[TBL] [Abstract][Full Text] [Related]
16. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
[TBL] [Abstract][Full Text] [Related]
17. [State of nucleolus-forming regions in bone marrow and blood cells in acute leukemia in children].
Ikonnikova OA; Lenskaia RV; Zatsepina OV; Baĭdun LV; Kondratchik KL; Chernov VM
Gematol Transfuziol; 1989 Sep; 34(9):28-33. PubMed ID: 2583458
[TBL] [Abstract][Full Text] [Related]
18. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
20. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
Pui CH
Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
